glucose, (beta-d)-isomer has been researched along with amphotericin b in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Björkstén, B; Quie, PG; Ray, C | 1 |
| Alais, J; David, S | 1 |
| Capuozzo, E; Crifò, C; Jullien, S; Salerno, C | 1 |
| Brown, EJ; Gresham, HD; McGarr, JA; Shackelford, PG | 1 |
| Campa, A; Marzzullo, L; Souza, LC | 1 |
| Afrin, F; Ali, I; Dutt, P; Khan, IA; Satti, NK; Sharma, P; Suri, KA | 1 |
| Cho, NJ; Fülöp, T; Jackman, JA; Mészáros, T; Szebeni, J; Urbanics, R | 1 |
| Dézsi, L; Fülöp, TG; Hamar, P; Hennies, M; Mészáros, T; Őrfi, E; Rosivall, L; Szebeni, J; Szénási, G | 1 |
8 other study(ies) available for glucose, (beta-d)-isomer and amphotericin b
| Article | Year |
|---|---|
Inhibition of human neutrophil chemotaxis and chemiluminescence by amphotericin B.
Topics: Amphotericin B; Cells, Cultured; Chemotaxis; Flucytosine; Griseofulvin; Humans; Luminescent Measurements; Miconazole; Neutrophils; Nystatin; Phagocytosis; Zymosan | 1976 |
A precursor to the beta-pyranosides of 3-amino-3,6-dideoxy-D-mannose (mycosamine).
Topics: Amphotericin B; Glucosides; Glycosides; Glycosylation; Hexosamines; Imidazoles; Mannosides | 1992 |
Effects of polyene antibiotics on the activation of human polymorphonuclear leukocytes.
Topics: Amphotericin B; Calcimycin; Dose-Response Relationship, Drug; Free Radicals; Humans; Kinetics; Latex; Luminescent Measurements; Lymphocyte Activation; Membrane Potentials; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxygen; Potassium; Tetradecanoylphorbol Acetate; Zymosan | 1991 |
Studies on the molecular mechanisms of human Fc receptor-mediated phagocytosis. Amplification of ingestion is dependent on the generation of reactive oxygen metabolites and is deficient in polymorphonuclear leukocytes from patients with chronic granulomat
Topics: Amphotericin B; Benzoates; Benzoic Acid; Biological Factors; Catalase; Cytokines; Free Radicals; Granulomatous Disease, Chronic; Humans; Lactoferrin; Male; Monocytes; NADH, NADPH Oxidoreductases; NADPH Oxidases; Neutrophils; Opsonin Proteins; Oxygen Consumption; Phagocytosis; Phorbol 12,13-Dibutyrate; Receptors, Fc; Zymosan | 1988 |
Effect of amphotericin B associated with a lipid emulsion on the oxidative burst of human polymorphonuclear leukocytes.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Cell Survival; Emulsions; Humans; In Vitro Techniques; Kinetics; Luminescent Measurements; Neutrophils; Respiratory Burst; Tetradecanoylphorbol Acetate; Triglycerides; Zymosan | 1997 |
In vitro antifungal activities of amphotericin B in combination with acteoside, a phenylethanoid glycoside from Colebrookea oppositifolia.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Biofilms; Candida albicans; Cryptococcus neoformans; Drug Synergism; Female; Glucosides; Lamiaceae; Male; Mice; Microbial Viability; Phenols | 2011 |
Comparison of complement activation-related pseudoallergy in miniature and domestic pigs: foundation of a validatable immune toxicity model.
Topics: Amphotericin B; Animals; Complement Activation; Disease Models, Animal; Doxorubicin; Drug Hypersensitivity; Glycerol; Humans; Liposomes; Nanomedicine; Nanoparticles; Polyethylene Glycols; Swine; Swine, Miniature; Zymosan | 2016 |
Complement Activation-Related Pathophysiological Changes in Anesthetized Rats: Activator-Dependent Variations of Symptoms and Mediators of Pseudoallergy.
Topics: Amphotericin B; Animals; Cholesterol; Complement Activation; Complement C3-C5 Convertases; Complement System Proteins; Drug Hypersensitivity Syndrome; Elapid Venoms; Humans; Hypotension; Leukocytosis; Leukopenia; Liposomes; Nanoparticles; Polyethylene Glycols; Rats; Thrombocytopenia; Zymosan | 2019 |